The same study showed that treatment of patients with anti-psoriatic drug alone or in combination with metformin caused a significant decrease in serum IL-2 compared with patients with psoriasis who did not receive treatment, with serum C-reactive protein also declining in patients treated in combination with metformin [50]. Here, IL2 is linked to psoriasis.